REPL Message Board Post 9944218 | Replimune Group Inc.
home / stock / repl / repl message board
Mdgchar
(investorshub)
Posted on: Oct/22/2020 18:11:53
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159060662
Updated corporate presentation (RP1 & RP2 data) https://ir.replimune.com/static-
News, Short Squeeze, Breakout and More Instantly...
-
2024-07-14 02:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors - - Financing follows strong primary analysis data from the RP1 IGNYTE clinical trial in anti-PD1 failed melanoma; BLA fi...
-
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that Sushil Patel, Chief Executive Officer of Replimune, will present at the Gold...